{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:30:26Z","timestamp":1792816226667,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"R\u00e9seau qu\u00e9b\u00e9cois de recherche sur le m\u00e9dicament"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The link between cardiovascular (CV) risk factors or diseases and dementia is documented. There is conflicting evidence whether age moderates the association. We need to study this gap so that research and clinical initiatives target appropriate age groups. A cohort of 320,630 adult patients without dementia was built using Quebec healthcare databases (1998\u20132010). The CV risk factors were hypertension, diabetes and dyslipidemia, while diseases included stroke, myocardial infarction (MI), chronic heart failure (HF), and atrial fibrillation (AF). Dementia risk and CV risk factors or diseases were assessed using incidence rate ratios and Cox regression across age groups. The cohort presented by mainly female sex (67.7%) and mean age of 74.1\u00a0years. Incident rate of dementia increased with age, ranging from 4.1 to 93.5 per 1000 person-years. Diabetes, stroke, HF and AF were significantly associated with dementia risk, hazard ratios ranged from 1.08 to 3.54. The strength of association decreased in advanced age for diabetes, stroke and HF. The results suggest that prevention of diabetes, stroke, HF and AF are crucial to mitigate dementia risk. The pathophysiology of dementia in younger and older populations seems to differ, with less impact of CV risk factors in advanced age.<\/jats:p>","DOI":"10.1038\/s41598-023-42071-8","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T06:02:32Z","timestamp":1694239352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association between cardiovascular diseases and dementia among various age groups: a population-based cohort study in older adults"],"prefix":"10.1038","volume":"13","author":[{"given":"Laurie-Anne","family":"Boivin-Proulx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Brouillette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Dorais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,9]]},"reference":[{"key":"42071_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","volume":"13","author":"A Wimo","year":"2017","unstructured":"Wimo, A. et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement. 13, 1\u20137. https:\/\/doi.org\/10.1016\/j.jalz.2016.07.150 (2017).","journal-title":"Alzheimers Dement."},{"key":"42071_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(14)61347-7","volume":"385","author":"MJ Prince","year":"2015","unstructured":"Prince, M. J. et al. The burden of disease in older people and implications for health policy and practice. Lancet 385, 549\u2013562. https:\/\/doi.org\/10.1016\/S0140-6736(14)61347-7 (2015).","journal-title":"Lancet"},{"key":"42071_CR3","doi-asserted-by":"publisher","first-page":"CD001190","DOI":"10.1002\/14651858.CD001190.pub2","volume":"1","author":"J Birks","year":"2006","unstructured":"Birks, J. & Harvey, R. Donepezil for dementia due to Alzheimer\u2019s disease. Cochrane Database Syst. Rev. 1, CD001190. https:\/\/doi.org\/10.1002\/14651858.CD001190.pub2 (2006).","journal-title":"Cochrane Database Syst. Rev."},{"key":"42071_CR4","doi-asserted-by":"publisher","first-page":"CD004746","DOI":"10.1002\/14651858.CD004746.pub2","volume":"4","author":"J Birks","year":"2006","unstructured":"Birks, J. & Craig, D. Galantamine for vascular cognitive impairment. Cochrane Database Syst. Rev. 4, CD004746. https:\/\/doi.org\/10.1002\/14651858.CD004746.pub2 (2006).","journal-title":"Cochrane Database Syst. Rev."},{"key":"42071_CR5","doi-asserted-by":"publisher","first-page":"CD004744","DOI":"10.1002\/14651858.CD004744.pub3","volume":"5","author":"J Birks","year":"2013","unstructured":"Birks, J., McGuinness, B. & Craig, D. Rivastigmine for vascular cognitive impairment. Cochrane Database Syst. Rev. 5, CD004744. https:\/\/doi.org\/10.1002\/14651858.CD004744.pub3 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"42071_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179777","author":"LT Nordestgaard","year":"2022","unstructured":"Nordestgaard, L. T., Christoffersen, M. & Frikke-Schmidt, R. Shared risk factors between dementia and atherosclerotic cardiovascular disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23179777 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"42071_CR7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/ejhf.1611","volume":"21","author":"C Vitale","year":"2019","unstructured":"Vitale, C. et al. Heart Failure Association\/European Society of Cardiology position paper on frailty in patients with heart failure. Eur. J. Heart Fail. 21, 1299\u20131305. https:\/\/doi.org\/10.1002\/ejhf.1611 (2019).","journal-title":"Eur. J. Heart Fail."},{"key":"42071_CR8","doi-asserted-by":"publisher","first-page":"870144","DOI":"10.3389\/fcvm.2022.870144","volume":"9","author":"N Stahr","year":"2022","unstructured":"Stahr, N. & Galkina, E. V. Immune response at the crossroads of atherosclerosis and Alzheimer\u2019s disease. Front. Cardiovasc. Med. 9, 870144. https:\/\/doi.org\/10.3389\/fcvm.2022.870144 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"42071_CR9","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1001\/jama.2022.2518","volume":"327","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Association of echocardiographic measures of left atrial function and size with incident dementia. JAMA 327, 1138\u20131148. https:\/\/doi.org\/10.1001\/jama.2022.2518 (2022).","journal-title":"JAMA"},{"key":"42071_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12916-015-0377-5","volume":"13","author":"RFAG de Bruijn","year":"2015","unstructured":"de Bruijn, R. F. A. G. et al. The potential for prevention of dementia across two decades: The prospective, population-based Rotterdam Study. BMC Med. 13, 132. https:\/\/doi.org\/10.1186\/s12916-015-0377-5 (2015).","journal-title":"BMC Med."},{"key":"42071_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s11906-022-01221-5","volume":"24","author":"JE Malone","year":"2022","unstructured":"Malone, J. E., Elkasaby, M. I. & Lerner, A. J. Effects of hypertension on Alzheimer\u2019s disease and related disorders. Curr. Hypertens. Rep. 24, 615\u2013625. https:\/\/doi.org\/10.1007\/s11906-022-01221-5 (2022).","journal-title":"Curr. Hypertens. Rep."},{"key":"42071_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/dc21-0601","volume":"45","author":"CA Celis-Morales","year":"2022","unstructured":"Celis-Morales, C. A. et al. Type 2 diabetes, glycemic control, and their association with dementia and its major subtypes: Findings from the Swedish National Diabetes Register. Diabetes Care 45, 634\u2013641. https:\/\/doi.org\/10.2337\/dc21-0601 (2022).","journal-title":"Diabetes Care"},{"key":"42071_CR13","doi-asserted-by":"publisher","first-page":"101723","DOI":"10.1016\/j.arr.2022.101723","volume":"81","author":"G Pasqualetti","year":"2022","unstructured":"Pasqualetti, G., Thayanandan, T. & Edison, P. Influence of genetic and cardiometabolic risk factors in Alzheimer\u2019s disease. Ageing Res. Rev. 81, 101723. https:\/\/doi.org\/10.1016\/j.arr.2022.101723 (2022).","journal-title":"Ageing Res. Rev."},{"key":"42071_CR14","doi-asserted-by":"publisher","first-page":"e025653","DOI":"10.1161\/JAHA.122.025653","volume":"11","author":"ME Giannone","year":"2022","unstructured":"Giannone, M. E. et al. Atrial fibrillation and the risk of early-onset dementia: A systematic review and meta-analysis. J. Am. Heart Assoc. 11, e025653. https:\/\/doi.org\/10.1161\/JAHA.122.025653 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"42071_CR15","doi-asserted-by":"publisher","first-page":"968039","DOI":"10.3389\/fnagi.2022.968039","volume":"14","author":"T Jamshidnejad-Tosaramandani","year":"2022","unstructured":"Jamshidnejad-Tosaramandani, T. et al. Statins and cognition: Modifying factors and possible underlying mechanisms. Front. Aging Neurosci. 14, 968039. https:\/\/doi.org\/10.3389\/fnagi.2022.968039 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"42071_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ana.25246","volume":"84","author":"MC Power","year":"2018","unstructured":"Power, M. C. et al. Combined neuropathological pathways account for age-related risk of dementia. Ann. Neurol. 84, 10\u201322. https:\/\/doi.org\/10.1002\/ana.25246 (2018).","journal-title":"Ann. Neurol."},{"key":"42071_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrcardio.2014.223","volume":"12","author":"C Qiu","year":"2015","unstructured":"Qiu, C. & Fratiglioni, L. A major role for cardiovascular burden in age-related cognitive decline. Nat. Rev. Cardiol. 12, 267\u2013277. https:\/\/doi.org\/10.1038\/nrcardio.2014.223 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"42071_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","volume":"134","author":"A Kapasi","year":"2017","unstructured":"Kapasi, A., DeCarli, C. & Schneider, J. A. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 134, 171\u2013186. https:\/\/doi.org\/10.1007\/s00401-017-1717-7 (2017).","journal-title":"Acta Neuropathol."},{"key":"42071_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13195-019-0496-x","volume":"11","author":"N Legdeur","year":"2019","unstructured":"Legdeur, N. et al. The association of vascular disorders with incident dementia in different age groups. Alzheimer\u2019s Res. Ther. 11, 47. https:\/\/doi.org\/10.1186\/s13195-019-0496-x (2019).","journal-title":"Alzheimer's Res. Ther."},{"key":"42071_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejphar.2008.02.049","volume":"585","author":"RP Kloppenborg","year":"2008","unstructured":"Kloppenborg, R. P., van den Berg, E., Kappelle, L. J. & Biessels, G. J. Diabetes and other vascular risk factors for dementia: Which factor matters most? A systematic review. Eur. J. Pharmacol. 585, 97\u2013108. https:\/\/doi.org\/10.1016\/j.ejphar.2008.02.049 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"42071_CR21","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/pds.4297","volume":"26","author":"ML Berger","year":"2017","unstructured":"Berger, M. L. et al. Good practices for real-world data studies of treatment and\/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making. Pharmacoepidemiol. Drug Saf. 26, 1033\u20131039. https:\/\/doi.org\/10.1002\/pds.4297 (2017).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"42071_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/pds.4295","volume":"26","author":"SV Wang","year":"2017","unstructured":"Wang, S. V. et al. Reporting to improve reproducibility and facilitate validity assessment for Healthcare Database Studies V1.0. Pharmacoepidemiol. Drug Saf. 26, 1018\u20131032. https:\/\/doi.org\/10.1002\/pds.4295 (2017).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"42071_CR23","doi-asserted-by":"publisher","first-page":"E689","DOI":"10.1503\/cmaj.190347","volume":"191","author":"SM Langan","year":"2019","unstructured":"Langan, S. M. et al. La d\u00e9claration RECORD-PE (Reporting of Studies Conducted Using Observational Routinely Collected Health Data Statement for Pharmacoepdemiology): Directives pour la communication des \u00e9tudes realis\u00e9es \u00e0 partir de donn\u00e9es de sant\u00e9 observationelles collect\u00e9es en routine en pharmaco\u00e9pid\u00e9miologie. CMAJ 191, E689\u2013E708. https:\/\/doi.org\/10.1503\/cmaj.190347 (2019).","journal-title":"CMAJ"},{"key":"42071_CR24","doi-asserted-by":"publisher","first-page":"m4856","DOI":"10.1136\/bmj.m4856","volume":"372","author":"SV Wang","year":"2021","unstructured":"Wang, S. V. et al. STaRT-RWE: Structured template for planning and reporting on the implementation of real world evidence studies. BMJ 372, m4856. https:\/\/doi.org\/10.1136\/bmj.m4856 (2021).","journal-title":"BMJ"},{"key":"42071_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0895-4356(03)00246-4","volume":"57","author":"M Wilchesky","year":"2004","unstructured":"Wilchesky, M., Tamblyn, R. M. & Huang, A. Validation of diagnostic codes within medical services claims. J. Clin. Epidemiol. 57, 131\u2013141. https:\/\/doi.org\/10.1016\/S0895-4356(03)00246-4 (2004).","journal-title":"J. Clin. Epidemiol."},{"key":"42071_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0895-4356(99)00136-5","volume":"53","author":"R Tamblyn","year":"2000","unstructured":"Tamblyn, R., Reid, T., Mayo, N., McLeod, P. & Churchill-Smith, M. Using medical services claims to assess injuries in the elderly: Sensitivity of diagnostic and procedure codes for injury ascertainment. J. Clin. Epidemiol. 53, 183\u2013194. https:\/\/doi.org\/10.1016\/s0895-4356(99)00136-5 (2000).","journal-title":"J. Clin. Epidemiol."},{"key":"42071_CR27","volume-title":"Validation of Administrative Data Algorithms to Determine Population Prevalence and Incidence of Alzheimer's Disease, Dementia, Multiple Sclerosis, Epilepsy and Parkinson's Disease","author":"K Tu","year":"2013","unstructured":"Tu, K. et al. Validation of Administrative Data Algorithms to Determine Population Prevalence and Incidence of Alzheimer\u2019s Disease, Dementia, Multiple Sclerosis, Epilepsy and Parkinson\u2019s Disease (Public Health Agency of Canada, 2013)."},{"key":"42071_CR28","unstructured":"R\u00e9gie de l\u2019Assurance Maladie du Qu\u00e9bec. Rapport Annuel de Gestion 2005\u20132006. (2006)."},{"key":"42071_CR29","volume-title":"Surveillance de la Maladie d\u2019Alzheimer et des Maladies Apparent\u00e9es: \u00c9tude de Faisabilit\u00e9 \u00e0 Partir des Fichiers Administratifs","author":"E Kr\u00f6ger","year":"2015","unstructured":"Kr\u00f6ger, E., Rochette, L., Gagne, M., Bocti, C. & \u00c9mond, V. Surveillance de la Maladie d\u2019Alzheimer et des Maladies Apparent\u00e9es: \u00c9tude de Faisabilit\u00e9 \u00e0 Partir des Fichiers Administratifs Vol. 10 (Institut National de Sant\u00e9 Publique du Qu\u00e9bec, Surveillance des Maladies Chroniques, 2015)."},{"key":"42071_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine, J. P. & Gray, R. J. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94, 496\u2013509. https:\/\/doi.org\/10.1080\/01621459.1999.10474144 (1999).","journal-title":"J. Am. Stat. Assoc."},{"key":"42071_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/HJH.0000000000002621","volume":"39","author":"A Scuteri","year":"2021","unstructured":"Scuteri, A. et al. Routine assessment of cognitive function in older patients with hypertension seen by primary care physicians: Why and how\u2014A decision-making support from the working group on \u201chypertension and the brain\u201d of the European Society of Hypertension and from the European Geriatric Medicine Society. J. Hypertens. 39, 90\u2013100. https:\/\/doi.org\/10.1097\/HJH.0000000000002621 (2021).","journal-title":"J. Hypertens."},{"key":"42071_CR32","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1212\/WNL.0000000000200521","volume":"99","author":"ER McGrath","year":"2022","unstructured":"McGrath, E. R. et al. Determining vascular risk factors for dementia and dementia risk prediction across mid- to later-life: The Framingham Heart Study. Neurology 99, e142-153. https:\/\/doi.org\/10.1212\/WNL.0000000000200521 (2022).","journal-title":"Neurology"},{"key":"42071_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jalz.2016.09.007","volume":"13","author":"MM Corrada","year":"2017","unstructured":"Corrada, M. M. et al. Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study. Alzheimers Dement. 13, 103\u2013110. https:\/\/doi.org\/10.1016\/j.jalz.2016.09.007 (2017).","journal-title":"Alzheimers Dement."},{"key":"42071_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.arr.2008.11.001","volume":"8","author":"SP Kennelly","year":"2009","unstructured":"Kennelly, S. P., Lawlor, B. A. & Kenny, R. A. Blood pressure and the risk for dementia: A double edged sword. Ageing Res. Rev. 8, 61\u201370. https:\/\/doi.org\/10.1016\/j.arr.2008.11.001 (2009).","journal-title":"Ageing Res. Rev."},{"key":"42071_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/s1474-4422(05)70141-1","volume":"4","author":"C Qiu","year":"2005","unstructured":"Qiu, C., Winblad, B. & Fratiglioni, L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 4, 487\u2013499. https:\/\/doi.org\/10.1016\/s1474-4422(05)70141-1 (2005).","journal-title":"Lancet Neurol."},{"key":"42071_CR36","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1093\/eurheartj\/ehy288","volume":"39","author":"JG Abell","year":"2018","unstructured":"Abell, J. G. et al. Association between systolic blood pressure and dementia in the Whitehall II cohort study: Role of age, duration, and threshold used to define hypertension. Eur. Heart J. 39, 3119\u20133125. https:\/\/doi.org\/10.1093\/eurheartj\/ehy288 (2018).","journal-title":"Eur. Heart J."},{"key":"42071_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/JGP.0b013e31816b72d4","volume":"16","author":"KJ Anstey","year":"2008","unstructured":"Anstey, K. J., Lipnicki, D. M. & Low, L. F. Cholesterol as a risk factor for dementia and cognitive decline: A systematic review of prospective studies with meta-analysis. Am. J. Geriatr. Psychiatry 16, 343\u2013354. https:\/\/doi.org\/10.1097\/JGP.0b013e31816b72d4 (2008).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"42071_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/circulationaha.117.029127","volume":"137","author":"J Sundb\u00f8ll","year":"2018","unstructured":"Sundb\u00f8ll, J. et al. Higher risk of vascular dementia in myocardial infarction survivors. Circulation 137, 567\u2013577. https:\/\/doi.org\/10.1161\/circulationaha.117.029127 (2018).","journal-title":"Circulation"},{"key":"42071_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3233\/jad-161208","volume":"58","author":"SJB Vos","year":"2017","unstructured":"Vos, S. J. B. et al. Modifiable risk factors for prevention of dementia in midlife, late life and the oldest-old: Validation of the LIBRA index. J. Alzheimers Dis. 58, 537\u2013547. https:\/\/doi.org\/10.3233\/jad-161208 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"42071_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2337\/db08-0586","volume":"58","author":"W Xu","year":"2009","unstructured":"Xu, W. et al. Mid- and late-life diabetes in relation to the risk of dementia: A population-based twin study. Diabetes 58, 71\u201377. https:\/\/doi.org\/10.2337\/db08-0586 (2009).","journal-title":"Diabetes"},{"key":"42071_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","volume":"5","author":"GJ Biessels","year":"2006","unstructured":"Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C. & Scheltens, P. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol. 5, 64\u201374. https:\/\/doi.org\/10.1016\/S1474-4422(05)70284-2 (2006).","journal-title":"Lancet Neurol."},{"key":"42071_CR42","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1212\/WNL.0b013e3181f4d7f8","volume":"75","author":"S Ahtiluoto","year":"2010","unstructured":"Ahtiluoto, S. et al. Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study. Neurology 75, 1195\u20131202. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f4d7f8 (2010).","journal-title":"Neurology"},{"key":"42071_CR43","doi-asserted-by":"publisher","first-page":"110085","DOI":"10.1016\/j.diabres.2022.110085","volume":"192","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Long-term glycemic variability and risk of adverse health outcomes in patients with diabetes: A systematic review and meta-analysis of cohort studies. Diabetes Res. Clin. Pract. 192, 110085. https:\/\/doi.org\/10.1016\/j.diabres.2022.110085 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"42071_CR44","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10741-011-9270-2","volume":"17","author":"JL Fleg","year":"2012","unstructured":"Fleg, J. L. & Strait, J. Age-associated changes in cardiovascular structure and function: A fertile milieu for future disease. Heart Fail. Rev. 17, 545\u2013554. https:\/\/doi.org\/10.1007\/s10741-011-9270-2 (2012).","journal-title":"Heart Fail. Rev."},{"key":"42071_CR45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijcard.2018.03.117","volume":"263","author":"A Scuteri","year":"2018","unstructured":"Scuteri, A. et al. An operational definition of SHATS (Systemic Hemodynamic Atherosclerotic Syndrome): Role of arterial stiffness and blood pressure variability in elderly hypertensive subjects. Int. J. Cardiol. 263, 132\u2013137. https:\/\/doi.org\/10.1016\/j.ijcard.2018.03.117 (2018).","journal-title":"Int. J. Cardiol."},{"key":"42071_CR46","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1212\/01.WNL.0000161870.78572.A5","volume":"64","author":"MM Mielke","year":"2005","unstructured":"Mielke, M. M. et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 64, 1689. https:\/\/doi.org\/10.1212\/01.WNL.0000161870.78572.A5 (2005).","journal-title":"Neurology"},{"key":"42071_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jalz.2016.08.017","volume":"13","author":"HC Hendrie","year":"2017","unstructured":"Hendrie, H. C. et al. Glucose level decline precedes dementia in elderly African Americans with diabetes. Alzheimers Dement. 13, 111\u2013118. https:\/\/doi.org\/10.1016\/j.jalz.2016.08.017 (2017).","journal-title":"Alzheimers Dement."},{"key":"42071_CR48","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3390\/brainsci12091214","volume":"12","author":"M Lenart-Bugla","year":"2022","unstructured":"Lenart-Bugla, M. et al. What do we know about social and non-social factors influencing the pathway from cognitive health to dementia? A systematic review of reviews. Brain Sci. 12, 1214. https:\/\/doi.org\/10.3390\/brainsci12091214 (2022).","journal-title":"Brain Sci."},{"key":"42071_CR49","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1002\/acn3.50936","volume":"6","author":"SC Conner","year":"2019","unstructured":"Conner, S. C. et al. Mid-life and late-life vascular risk factor burden and neuropathology in old age. Ann. Clin. Transl. Neurol. 6, 2403\u20132412. https:\/\/doi.org\/10.1002\/acn3.50936 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"42071_CR50","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1212\/wnl.0000000000001831","volume":"85","author":"CH Kawas","year":"2015","unstructured":"Kawas, C. H. et al. Multiple pathologies are common and related to dementia in the oldest-old: The 90+ study. Neurology 85, 535\u2013542. https:\/\/doi.org\/10.1212\/wnl.0000000000001831 (2015).","journal-title":"Neurology"},{"key":"42071_CR51","doi-asserted-by":"publisher","first-page":"15673","DOI":"10.1038\/s41598-022-20072-3","volume":"12","author":"S Cho","year":"2022","unstructured":"Cho, S. et al. Association of cardiovascular health with the risk of dementia in older adults. Sci. Rep. 12, 15673. https:\/\/doi.org\/10.1038\/s41598-022-20072-3 (2022).","journal-title":"Sci. Rep."},{"key":"42071_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12818","author":"S Sedaghat","year":"2022","unstructured":"Sedaghat, S. et al. Association of change in cardiovascular risk factors with incident dementia. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12818 (2022).","journal-title":"Alzheimers Dement."},{"key":"42071_CR53","doi-asserted-by":"publisher","first-page":"e2013","DOI":"10.1212\/WNL.0000000000200255","volume":"98","author":"B Farnsworth von Cederwald","year":"2022","unstructured":"Farnsworth von Cederwald, B., Josefsson, M., Wahlin, A., Nyberg, L. & Karalija, N. Association of cardiovascular risk trajectory with cognitive decline and incident dementia. Neurology 98, e2013\u2013e2022. https:\/\/doi.org\/10.1212\/WNL.0000000000200255 (2022).","journal-title":"Neurology"},{"key":"42071_CR54","doi-asserted-by":"publisher","first-page":"e0271611","DOI":"10.1371\/journal.pone.0271611","volume":"17","author":"J Brain","year":"2022","unstructured":"Brain, J. et al. Risk factors for dementia in the context of cardiovascular disease: A protocol of an overview of reviews. PLoS ONE 17, e0271611. https:\/\/doi.org\/10.1371\/journal.pone.0271611 (2022).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42071-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42071-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42071-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T12:16:12Z","timestamp":1700309772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42071-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,9]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42071"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-42071-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2851970\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,9]]},"assertion":[{"value":"23 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no non-financial interests to declare that are relevant to the content of this article. S.P. has received research support from the <i>R\u00e9seau qu\u00e9b\u00e9cois de recherche sur le m\u00e9dicament<\/i> (RQRM). M.D. is consultant to StatSciences Inc. and has received consultant honorarium from S.P. (Faculty of Pharmacy, University of Montreal) with the research support provided by the <i>R\u00e9seau qu\u00e9b\u00e9cois de recherche sur le m\u00e9dicament<\/i> (RQRM). L-A. B-P. and J.B. declare they have no financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14881"}}